 |
|
buserelin
A synthetic analog of gonadotropin-releasing hormone (GnRH). Buserelin binds to and activates pituitary gonadotropin releasing hormone (GnRH) receptors. Prolonged administration of buserelin results in sustained inhibition of gonadotropin production, suppression of testicular and ovarian steroidogenesis, and reduced levels of circulating gonadotropin and gonadal steroids. Buserelin is more potent that GnRH. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | buserelin acetate
busereline | | | | US brand name: | | Etilamide | | | | Foreign brand names: | | Bigonist
Profact
Profact Depot
Receptal
Suprecur
Suprefact
Suprefact Depot
Suprefact Flakon | | | | Abbreviation: | | BSRL | | | | Code names: | | HOE 766
ICI 123215
S74-6766 | | | | Chemical structure names: | | - 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide luteinizing hormone-releasing factor (pig)
- D-ser (bu(t))(6) pro(9) NEt LHRH Acetate
| | |
|
|
